Scynexis (SCYX) EBITDA (2013 - 2026)
Scynexis (SCYX) reported EBITDA of -$16.9 million for Q1 2026, down 96.74% on a YoY basis from -$519.0 million in Q1 2025, and down 168.33% quarter-over-quarter from $24.8 million in Q4 2025.
Scynexis (SCYX) EBITDA (2013 - 2026) Analysis & Trends
Scynexis has reported EBITDA for 14 years, with the latest figure at -$16.9 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA fell 96.74% year-over-year to -$16.9 million; the trailing twelve-month figure through Mar 2026 stood at -$10.1 million (up 72.07% YoY), and the FY2025 full-year result was -$1.8 million, up 95.13% from the prior year.
- EBITDA for Q1 2026 stood at -$16.9 million, down from $24.8 million in the prior quarter.
- The five-year high for EBITDA was $116.5 million in Q2 2023, with the low at -$23.1 million in Q4 2023.
- Historically, EBITDA has averaged -$4.1 million across 5 years, with a median of -$10.1 million in 2023.
- Annual changes were most pronounced in 2022 — EBITDA plunged 1138.27% — and 2023, when it jumped 635.99%.
- Scynexis' EBITDA stood at -$22.5 million in 2022, then dropped by 2.6% to -$23.1 million in 2023, then soared by 65.09% to -$8.1 million in 2024, then soared by 407.82% to $24.8 million in 2025, then sank by 168.33% to -$16.9 million in 2026.
- The last three EBITDA figures came in at -$16.9 million (Q1 2026), $24.8 million (Q4 2025), and -$8.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -98.81 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | -16.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.94 Mn |
| Dec 31, 2025 | 24.79 Mn |
| Sep 30, 2025 | -8.41 Mn |
| Jun 30, 2025 | -9.56 Mn |
| Mar 31, 2025 | -8.61 Mn |
| Dec 31, 2024 | -8.05 Mn |
| Sep 30, 2024 | -10.32 Mn |
| Jun 30, 2024 | -9.24 Mn |
| Mar 31, 2024 | -9.51 Mn |
| Dec 31, 2023 | -23.07 Mn |
| Sep 30, 2023 | -10.10 Mn |
| Jun 30, 2023 | 116.51 Mn |
| Mar 31, 2023 | -10.68 Mn |
| Dec 31, 2022 | -22.48 Mn |
| Sep 30, 2022 | -21.80 Mn |
| Jun 30, 2022 | -21.74 Mn |
| Mar 31, 2022 | -19.74 Mn |
| Dec 31, 2021 | 30.76 Mn |
| Sep 30, 2021 | -19.44 Mn |
| Jun 30, 2021 | -17.51 Mn |